Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging

Neurology

Volumn 50, Issue 4, 1998, Pages 986-990

  Mackenzie, Ian R A ^a   Munoz, David G ^b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NONSTEROID ANTIINFLAMMATORY AGENT; TAU PROTEIN;

AGED; AGING; ALZHEIMER DISEASE; ARTHRITIS; ARTICLE; AUTOPSY; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MICROGLIA; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0031900411     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.4.986     Document Type: Article

References (37)

1. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996;47:425-432.
2. Stewart WF, Kawas C, Corrada M, Metter EJ. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997;48: 626-632.
3. Rogers J, Kirby LC, Hempielman SR, et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993;43: 1609-1611.
4. Coria F, Moreno A, Rubio I, Garcia MA, Morato E, Mayor F. The cellular pathology associated with Alzheimer β-amyloid deposits in non-demented aged individuals. Neuropathol Appl Neurobiol 1993;19:261-268.
5. Griffin WST, Sheng JG, Roberts GW, Mrak RE. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 1995;54:276-281.
6. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 1989;24:173-182.
7. Lue LF, Brachova L, Civin WH, Rogers J. Inflammation, Aβ deposition and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J Neuropathol Exp Neurol 1996;55:1083-1088.
8. Mattice LA, Davies P, Dickson DW. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol 1990;136:1101-1114.
9. McGeer PL, Akiyama H, Itagaki S, McGeer EG. Immune system response in Alzheimer's disease. Can J Neurol Sci 1989; 16:516-527.
10. McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 1995;21:195-218.
11. McGeer PL, Rogers J, McGeer EG. Neuroimmune mechanisms in Alzheimer disease pathogenesis. Alz Dis Assoc Disord 1994;8:149-158.
12. Ohgami T, Kitamoto T, Shin RW, Kaneko Y, Ogomori K, Tateishi J. Increased senile plaques without microglia in Alzheimer's disease. Acta Neuropathol 1991;81:242-247.
13. Rozemuller JM, Eikelenboom P, Stam FC, Beyreuther K, Masters CL. A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol 1989;48:674-691.
14. Styren SD, Civin WH, Rogers J. Molecular, cellular and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain. Exp Neurol 1990;110:93-104.
15. Joachim CL, Selkoe DJ. The seminal role of β-amyloid in the pathogenesis of Alzheimer disease. Alzheimer Dis Assoc Disord 1992;6:7-34.
16. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991;6:487-498.
17. Cras P, Kawai M, Lowery D, Gonzales-DeWhitt P, Greenberg B, Perry G. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci USA 1991;88:7552-7556.
18. Wang D, Munoz DG. Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain. J Neuropathol Exp Neurol 1995;54: 548-556.
19. Mann DMA, Esiri MM. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 1989;89:169-179.
20. Motte J, Williams RS. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathol 1989;77:535-546.
21. Mackenzie IRA. Senile plaques do not progressively accumulate with normal aging. Acta Neuropathol 1994;87:520-525.
22. Mackenzie IRA, Hao C, Munoz DG. The role of microglia in senile plaque formation. Neurobiol Aging 1995;16:797-804.
23. Cotman CW, Tenner AJ, Cummings BJ. β-Amyloid converts an acute phase injury response to chronic injury responses. Neurobiol Aging 1996;17:723-731.
24. Giulian D, Haverkamp LJ, Yu JH, et al. Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J Neurosci 1996;16:6021-6037.
25. Goodwin JL, Uemura E, Cunnick JE. Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-δ. Brain Res 1995;692:207-214.
26. Berr C, Hauw JJ, Delaere P, Duyckaerts C, Amouyel P. Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. Neurosci Lett 1994;178:221-224.
27. Wenham PR, Price WH, Blundell G. Apolipoprotein E geno-typing by one-stage PCR. Lancet 1991;337:1158-1159.
28. Crook R, Hardy J, Duff K. Single day apolipoprotein E geno-typing. J Neurosci Methods 1994;53:125-127.
29. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
30. Graeber MB, Bise K, Mehraein P. CR3/43, a marker for activated human microglia: application to diagnostic neuropathology. Neuopathol Appl Neurobiol 1994;20:406-408.
31. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
32. Davies L, Wolska B, Hilbich C, et al. A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunohistochemistry compared with conventional neuropathologic techniques. Neurology 1988;38:1688-1693.
33. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991; 12:295-312.
34. Graham DI, Gentleman SM, Lynch A, Roberts GW. Distribution of β-amyloid protein in the brain following severe head injury. Neuropathol Appl Neurobiol 1995;21:27-34.
35. Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI. β-Amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1994;57: 419-425.
36. Mackenzie IRA, Kaye KL, Munoz DG. The effect of anti-inflammatory drugs on senile plaque formation. J Neuropathol Exp Neurol 1995;54:427.
37. Mackenzie IRA. The effect of chronic anti-inflammatory drug use on brain microglia. Can J Neurol Sci 1996;23:153-154.